Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Taxes (2022 - 2025)

Sunshine Biopharma (SBFM) has disclosed Current Taxes for 4 consecutive years, with $258158.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Current Taxes rose 1.25% year-over-year to $258158.0, compared with a TTM value of $258158.0 through Jun 2025, up 1.25%, and an annual FY2024 reading of $268276.0, down 10.54% over the prior year.
  • Current Taxes was $258158.0 for Q2 2025 at Sunshine Biopharma, up from $228115.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $416245.0 in Q1 2023 and bottomed at $201541.0 in Q3 2023.
  • Average Current Taxes over 4 years is $276444.5, with a median of $254971.0 recorded in 2024.
  • Peak annual rise in Current Taxes hit 26.51% in 2024, while the deepest fall reached 38.74% in 2024.
  • Year by year, Current Taxes stood at $373191.0 in 2022, then fell by 19.65% to $299869.0 in 2023, then decreased by 10.54% to $268276.0 in 2024, then decreased by 3.77% to $258158.0 in 2025.
  • Business Quant data shows Current Taxes for SBFM at $258158.0 in Q2 2025, $228115.0 in Q1 2025, and $268276.0 in Q4 2024.